Junnan Liang

1.3k total citations · 1 hit paper
26 papers, 792 citations indexed

About

Junnan Liang is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Junnan Liang has authored 26 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Junnan Liang's work include RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (7 papers). Junnan Liang is often cited by papers focused on RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (7 papers). Junnan Liang collaborates with scholars based in China and United States. Junnan Liang's co-authors include Liang Chu, Jingyuan Wen, Bixiang Zhang, Zhao Huang, Xiaoping Chen, Jingyu Liao, Huifang Liang, Zeyang Ding, Jin Chen and Shasha Song and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Cell Death and Differentiation.

In The Last Decade

Junnan Liang

26 papers receiving 786 citations

Hit Papers

Neuroscience of cancer: unraveling the complex interplay ... 2025 2026 2025 5 10 15
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor and the tumor immune microenvironment
    2025 16 citations Zhang Ping, Ye Yuan et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junnan Liang China 13 583 390 114 78 55 26 792
Jianfeng Zheng China 14 355 0.6× 232 0.6× 105 0.9× 103 1.3× 79 1.4× 47 633
Jian Xiao China 17 460 0.8× 315 0.8× 63 0.6× 78 1.0× 81 1.5× 41 819
Yingying Liu China 16 503 0.9× 446 1.1× 89 0.8× 63 0.8× 24 0.4× 39 752
Mai A. Abd‐Elmawla Egypt 17 453 0.8× 437 1.1× 70 0.6× 36 0.5× 43 0.8× 58 711
Yeyang Xu China 10 523 0.9× 397 1.0× 107 0.9× 79 1.0× 41 0.7× 17 710
Liang Shi China 16 502 0.9× 275 0.7× 130 1.1× 87 1.1× 32 0.6× 39 828
Zhicong Zhao China 13 524 0.9× 280 0.7× 65 0.6× 36 0.5× 35 0.6× 39 710
Xing‐dong Xiong China 17 710 1.2× 551 1.4× 57 0.5× 32 0.4× 60 1.1× 47 880

Countries citing papers authored by Junnan Liang

Since Specialization
Citations

This map shows the geographic impact of Junnan Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junnan Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junnan Liang more than expected).

Fields of papers citing papers by Junnan Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junnan Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junnan Liang. The network helps show where Junnan Liang may publish in the future.

Co-authorship network of co-authors of Junnan Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Junnan Liang. A scholar is included among the top collaborators of Junnan Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junnan Liang. Junnan Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ping, Zhang, Ye Yuan, Xiaoping Chen, et al.. (2025). Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor and the tumor immune microenvironment. Molecular Cancer. 24(1). 24–24. 16 indexed citations breakdown →
2.
Wu, Xing, et al.. (2024). B cells and tertiary lymphoid structures in tumors: immunity cycle, clinical impact, and therapeutic applications. Theranostics. 15(2). 605–631. 6 indexed citations
3.
Wen, Jingyuan, Xue Lin, Wei Yi, et al.. (2024). YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5/PD‐L1/VEGFA Axis. Advanced Science. 11(13). e2307242–e2307242. 39 indexed citations
4.
5.
Wei, Yi, Tuying Yong, Wenlong Jia, et al.. (2023). Bone Lesion‐Derived Extracellular Vesicles Fuel Prometastatic Cascades in Hepatocellular Carcinoma by Transferring ALKBH5‐Targeting miR‐3190‐5p. Advanced Science. 10(17). e2207080–e2207080. 19 indexed citations
6.
Li, Ganxun, et al.. (2023). IMOPAC: A web server for interactive multiomics and pharmacological analyses of patient-derived cancer cell lines. Computational and Structural Biotechnology Journal. 21. 3705–3714. 1 indexed citations
7.
Wei, Yi, Jingyuan Wen, Jingyu Liao, et al.. (2023). E26 transformation-specific transcription variant 5 in development and cancer: modification, regulation and function. Journal of Biomedical Science. 30(1). 17–17. 10 indexed citations
8.
Liao, Jingyu, Zeyu Chen, Tong Yuan, et al.. (2023). CENPA functions as a transcriptional regulator to promote hepatocellular carcinoma progression via cooperating with YY1. International Journal of Biological Sciences. 19(16). 5218–5232. 47 indexed citations
9.
Liao, Jingyu, Yi Wei, Junnan Liang, et al.. (2022). Insight into the structure, physiological function, and role in cancer of m6A readers—YTH domain-containing proteins. Cell Death Discovery. 8(1). 137–137. 66 indexed citations
10.
Huang, Zhao, Jingyuan Wen, Yufei Wang, et al.. (2022). Bone metastasis of hepatocellular carcinoma: facts and hopes from clinical and translational perspectives. Frontiers of Medicine. 16(4). 551–573. 10 indexed citations
11.
Wen, Jingyuan, Zhao Huang, Yi Wei, et al.. (2022). Hsa-microRNA-27b-3p inhibits hepatocellular carcinoma progression by inactivating transforming growth factor-activated kinase-binding protein 3/nuclear factor kappa B signalling. Cellular & Molecular Biology Letters. 27(1). 79–79. 10 indexed citations
12.
Liang, Junnan, Ganxun Li, Jingyu Liao, et al.. (2022). Non-coding small nucleolar RNA SNORD17 promotes the progression of hepatocellular carcinoma through a positive feedback loop upon p53 inactivation. Cell Death and Differentiation. 29(5). 988–1003. 43 indexed citations
13.
Zhu, Jinghan, Ning Deng, Ganxun Li, et al.. (2022). A Novel hepatocellular carcinoma specific hypoxic related signature for predicting prognosis and therapeutic responses. Frontiers in Immunology. 13. 997316–997316. 4 indexed citations
14.
Liang, Junnan, Guan-nan Jin, Tongtong Liu, et al.. (2021). Clinical characteristics and risk factors for mortality in cancer patients with COVID-19. Frontiers of Medicine. 15(2). 264–274. 30 indexed citations
15.
Fu, Wan, Junnan Liang, Fan Pan, et al.. (2021). miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4. Frontiers in Oncology. 10. 563486–563486. 18 indexed citations
16.
Wen, Jingyuan, Jingyu Liao, Junnan Liang, et al.. (2020). Circular RNA HIPK3: A Key Circular RNA in a Variety of Human Cancers. Frontiers in Oncology. 10. 773–773. 57 indexed citations
17.
Liang, Junnan, Jingyu Liao, Tongtong Liu, et al.. (2020). Comprehensive analysis of TGF-β-induced mRNAs and ncRNAs in hepatocellular carcinoma. Aging. 12(19). 19399–19420. 11 indexed citations
18.
Song, Shasha, Liang Chu, Huifang Liang, et al.. (2019). Protective Effects of Dioscin Against Doxorubicin-Induced Hepatotoxicity Via Regulation of Sirt1/FOXO1/NF-κb Signal. Frontiers in Pharmacology. 10. 1030–1030. 116 indexed citations
19.
Wang, Yigang, Junnan Liang, Caixia Cui, et al.. (2019). <p>Oncolytic viro-chemotherapy exhibits antitumor effect in laryngeal squamous cell carcinoma cells and mouse xenografts</p>. Cancer Management and Research. Volume 11. 3285–3294. 2 indexed citations
20.
Liang, Junnan, Jingyuan Wen, Zhao Huang, et al.. (2019). Small Nucleolar RNAs: Insight Into Their Function in Cancer. Frontiers in Oncology. 9. 587–587. 192 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianfeng Zheng Breakdown of academic impact, for papers by Jian Xiao Breakdown of academic impact, for papers by Yingying Liu Breakdown of academic impact, for papers by Mai A. Abd‐Elmawla Breakdown of academic impact, for papers by Yeyang Xu Breakdown of academic impact, for papers by Liang Shi Breakdown of academic impact, for papers by Zhicong Zhao Breakdown of academic impact, for papers by Xing‐dong Xiong
Rankless by CCL
2026